These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35730296)

  • 21. Identification of Molecular Subtypes and Prognostic Characteristics of Adrenocortical Carcinoma Based on Unsupervised Clustering.
    Zhang Y; Zhang C; Li K; Deng J; Liu H; Lai G; Xie B; Zhong X
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma.
    Shen C; Wang Y
    Arch Med Res; 2023 Jan; 54(1):45-55. PubMed ID: 36528469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
    Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
    Front Genet; 2021; 12():623424. PubMed ID: 33664769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Lv J; Zhu Y; Ji A; Zhang Q; Liao G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.
    Chen Y; Chen J; Shi Y; Ling X; Fang S; Zhong C; Liu F; Zhong W; Bi X; Dong Z; Lu J
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38224097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
    Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
    Xie F; Bai Y; Yang X; Long J; Mao J; Lin J; Wang D; Song Y; Xun Z; Huang H; Yang X; Zhang L; Mao Y; Sang X; Zhao H
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107135. PubMed ID: 33189609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
    Lin J; Lin Y; Huang Z; Li X
    Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in
    Wen Y; Ouyang D; Chen Q; Zeng L; Luo N; He H; Anwar M; Qu L; Zou Q; Yi W
    Gland Surg; 2022 Jan; 11(1):100-114. PubMed ID: 35242673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Analysis of Mutation Status and Immune Landscape for Squamous Cell Carcinomas at Different Anatomical sites.
    Ti W; Wei T; Wang J; Cheng Y
    Front Immunol; 2022; 13():947712. PubMed ID: 35935970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
    Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z
    Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    Ji D; Zhong R; Fan S
    Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
    Zhang C; Shen L; Qi F; Wang J; Luo J
    J Cell Physiol; 2020 Apr; 235(4):3849-3863. PubMed ID: 31596511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
    Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
    Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
    Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
    Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma.
    Gao J; Wang D; Yang Q; Tang M; Du J; He L; Liu W
    Front Mol Biosci; 2023; 10():1131402. PubMed ID: 36911522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
    Tian X; Xu W; Wang Y; Anwaier A; Wang H; Wan F; Zhu Y; Cao D; Shi G; Zhu Y; Qu Y; Zhang H; Ye D
    Oncoimmunology; 2020 Jun; 9(1):1784529. PubMed ID: 32923148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.